Scientists designed a new molecule, 7c, that acts like a specific key for the HDAC3 enzyme, often overactive in aggressive breast cancer. Its unique structure, including chirality, enhances selectivity. Preclinical studies show it effectively fights tumours in mice by triggering cell death and stopping spread.